MTHFR and non-small cell lung carcinoma: MTHFR rs1801131 interacts with the metabolism of fluoropyrimidines and platinum drugs and is known to affect the efficiency of chemotherapy in colorectal, breast and non-small-cell lung cancers [144,145,146].